Penicillin G (Potassium and Sodium)

Brand names: Penicillin G Potassium · Active ingredient: Penicillin G Potassium

In short: Penicillin G Potassium for Injection is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organi

LabelAvenacy, LLC
Label updatedNov 13, 2026

What is Penicillin G (Potassium and Sodium) used for?

Penicillin G Potassium for Injection is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below.

Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G.

Therapy with Penicillin G Potassium for Injection may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below; however, once these results become available, appropriate therapy should be continued.

CLINICAL INDICATION | INFECTING ORGANISM

Septicemia, empyema, pneumonia, pericarditis, endocarditis, meningitis | Streptococcus pyogenes (group A β-hemolytic streptococcus), other β-hemolytic streptococci including groups C, H, G, L and M, Streptococcus pneumoniae and Staphylococcus species (non-penicillinase producing strains)

Anthrax | Bacillus anthracis

Actinomycosis (cervico-facial disease and thoracic and abdominal disease) | Actinomyces israelii

Botulism (adjunctive therapy to antitoxin), gas gangrene, and tetanus (adjunctive therapy to human tetanus immune globulin) | Clostridium species

Diphtheria (adjunctive therapy to antitoxin and prevention of the carrier state) | Corynebacterium diphtheriae

Erysipelothrix endocarditis | Erysipelothrix rhusiopathiae

Fusospirochetosis (severe infections of the oropharynx …

âš  Boxed warning (FDA's strongest warning)

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and/or a history of sensitivity to multiple allergens. There have been reports of individuals with a history of penicillin hypersensitivity who have experienced severe reactions when treated with cephalosporins. Before initiating therapy with penicillin G, careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens. If an allergic reaction occurs, penicillin G should be discontinued and appropriate therapy instituted.

Severe cutaneous adverse reactions (SCAR), such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP) have been reported in patients taking beta-lactam antibiotics. When SCAR is suspected, Penicillin G Potassium for Injection should be discontinued immediately and an alternative treatment should be considered.

Clostridioides difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Penicillin G Potassium for Injection and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.

C. difficile produces toxins A and B which contribute to the development of CDAD. …

Penicillin G (Potassium and Sodium) dosage

Buffered Penicillin G Potassium for Injection, USP may be given intravenously or intramuscularly. The usual dose recommendations are as follows:

* Because of its short half-life, Penicillin G is administered in divided doses, usually every 4 to 6 hours with the exception of meningococcal meningitis/septicemia, i.e., every 2 hours.

CLINICAL INDICATION | DOSAGE

Serious infections due to susceptible strains of streptococci (including S. pneumoniae)

-

septicemia, empyema, pneumonia, pericarditis, endocarditis and meningitis | 12 to 24 million units/day depending on the infection and its severity administered in equally divided doses every 4 to 6 hours

Serious infections due to susceptible strains of staphylococci

-

septicemia, empyema, pneumonia, pericarditis, endocarditis and meningitis | 5 to 24 million units/day depending on the infection and its severity administered in equally divided doses every 4 to 6 hours

Anthrax | Minimum of 8 million units/day in divided doses every 6 hours. Higher doses may be required depending on susceptibility of organism

Actinomycosis Cervicofacial disease Thoracic and abdominal disease | 1 to 6 million units/day*10 to 20 million units/day*

Clostridial infections

Botulism (adjunctive therapy to antitoxin)

Gas gangrene (debridement and/or surgery as indicated)

Tetanus (adjunctive therapy to human tetanus immune globulin) | 20 million units/day*

Diphtheria (adjunctive therapy to antitoxin and for the prevention of the carrier state) | 2 to 3 million units/day in divided doses for 10 to 12 days*

Erysipelothrix endocarditis | 12 to 20 million units/day for 4 to 6 weeks*

Fusospirochetosis (severe infections of the oropharynx [Vincent's], lower respiratory tract and genital area) | 5 to 10 million units/day*

Listeria infections Meningitis Endocarditis | 15 to 20 million units/day for 2 weeks*15 to 20 million units/day for 4 weeks*

Pasteurella infections including bacteremia and meningitis | 4 to 6 million units/day for 2 weeks*

Haverhill fever; Rat-bite fever | 12 to 20 million units/day for 3 to 4 weeks*

Disseminated gonococcal infections, such as meningitis, endocarditis, arthritis, etc., caused by penicillin-susceptible organisms | 10 million units/day*, duration depends on the type of infection

Syphilis (neurosyphilis) | 12 to 24 million units/day, as 2 to 4 MU every 4 hours for 10 to 14 days; many experts recommend additional therapy with Benzathine PCN G 2.4 MU IM weekly for 3 doses after completion of IV therapy

Meningococcal meningitis and/or septicemia | 24 million units/day as 2 million units every 2 hours

This product should not be administered to patients requiring less than one million units per dose . …

Warnings & precautions

Do not take this medicine if: A history of a hypersensitivity (anaphylactic) reaction to any penicillin is a contraindication.

Penicillin should be used with caution in individuals with histories of significant allergies and/or asthma . Whenever allergic reactions occur, penicillin should be withdrawn unless, in the opinion of the physician, the condition being treated is life-threatening and amenable only to penicillin therapy. Penicillin G Potassium for Injection by the intravenous route in high doses (above 10 million units) should be administered slowly because of the potential adverse effects of electrolyte imbalance from the potassium content of the penicillin. Penicillin G Potassium for Injection contains 1.68 mEq potassium and 0.3 mEq of sodium per million units. The use of antibiotics may promote overgrowth of nonsusceptible organisms, including fungi. Indwelling intravenous catheters encourage superinfections. Should superinfection occur, appropriate measures should be taken. When indicated, incision and drainage or other surgical procedures should be performed in conjunction with antibiotic therapy.

Prescribing Penicillin G Potassium for Injection in the absence of proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.

Care should be taken to avoid intravenous or accidental intraarterial administration, or injection into or near major peripheral nerves or blood vessels, since such injections may produce neurovascular damage. Particular care should be taken with IV administration because of the possibility of thrombophlebitis.

Patients should be counseled that antibacterial drugs including Penicillin G Potassium for Injection should only be used to treat bacterial infections. …

Penicillin G (Potassium and Sodium) side effects

The Jarisch-Herxheimer reaction is a systemic reaction that may occur after the initiation of penicillin therapy in patients with syphilis or other spirochetal infections (i.e., Lyme disease and Relapsing fever). The reaction begins one or two hours after initiation of therapy and disappears within 12 to 24 hours. It is characterized by fever, chills, myalgias, headache, exacerbation of cutaneous lesions, tachycardia, hyperventilation, vasodilation with flushing and mild hypotension. The pathogenesis of the Herxheimer reaction may be due to the release from the spirochetes of heat-stable pyrogen.

The reported incidence of allergic reactions to all penicillins ranges from 0.7 to 10 percent in different studies . Sensitization is usually the result of previous treatment with a penicillin, but some individuals have had immediate reactions when first treated. In such cases, it is postulated that prior exposure to penicillin may have occurred via trace amounts present in milk or vaccines.

Two types of allergic reactions to penicillin are noted clinically - immediate and delayed.

Immediate reactions usually occur within 20 minutes of administration and range in severity from urticaria and pruritus to angioneurotic edema, laryngospasm, bronchospasm, hypotension, vascular collapse and death . Such immediate anaphylactic reactions are very rare and usually occur after parenteral therapy, but a few cases of anaphylaxis have been reported following oral therapy. …

About this medicine

Buffered Penicillin G Potassium for Injection, USP is a sterile, pyrogen-free powder for reconstitution. Buffered Penicillin G Potassium for Injection, USP is an antibacterial agent for intramuscular, continuous intravenous infusion, intrapleural or other local infusion, and intrathecal administration.

Each million units contains approximately 6.8 milligrams of sodium (0.3 mEq) and 65.6 milligrams of potassium (1.68 mEq). Buffered Penicillin G Potassium for Injection, USP is supplied in vials equivalent to 5,000,000 units (5 million units) or 20,000,000 units (20 million units) of penicillin G as the potassium salt.

Chemically, Penicillin G Potassium for Injection, USP is monopotassium 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo (3.2.0) heptane-2-carboxylate. It has a molecular weight of 372.48 and the following chemical structure:

Formula: C16H17KN2O4S

Penicillin G potassium is a colorless or white crystal, or a white crystalline powder which is odorless, or practically so, and moderately hygroscopic. Penicillin G potassium is very soluble in water. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 969a421e-37d8-499e-9e89-67e210bd5d9d. Read the full official label on DailyMed.

Related medicines

Amoxicillin Azithromycin Doxycycline Amoxicillin and Clavulanate Cephalexin Valacyclovir Sulfamethoxazole and Trimethoprim Nitrofurantoin